Luke M. Beshar - 07 Jun 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Reporting relationship: Director
Issuer ticker: OMGAQ
Reported as of: 07 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2023, 16:05:26 UTC
Prior SEC filing: 05 Jul 2022
Next SEC filing: 10 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Barbara Chan as Attorney-in-Fact for Luke M. Beshar

Key filing fact

Luke M. Beshar filed Form 4 for Omega Therapeutics, Inc. (OMGAQ) on 09 Jun 2023.

Key facts

This page summarizes Luke M. Beshar's Form 4 filing for Omega Therapeutics, Inc. (OMGAQ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2023, 16:05.

Change

Previous filing in this sequence was filed on 05 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OMGA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +18,118
Change %
Price: $0.000000
Shares after: 18,118
Date: 07 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,118
Exercise price: $8.39
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date.